Post-Authorization Safety Study Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine (DNG15-Post Authorisation safety Surveillance study)

First published 06/08/2019

Last updated 04/10/2024

EU PAS number:

EUPAS28947

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

rdct-dng15-amended-protocol10.pdf

English (1.88 MB - PDF)View document

Study results

Study report

Study report

rdct-dng15-csr-synopsis.pdf

English (187.65 KB - PDF)View document

Other information

ENCePP Seal

ENCePP Seal documents